ERD

'IV imatinib in severe Covid-19' study peer reviewed publication

Project: Impentri

Updated at: 29-04-2024

Show more information

Project acronym Impentri

Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib s...

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

'Oral imatinib in severe Covid-19' study peer reviewed publication

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients ...

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

90-Day Clinical Outcome of Hospitalized Covid-19 Patients Treated with Imatinib

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Long-term clinical outcomes of COVID-19 patients treated with imatinib

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of...

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Oral Imatinib Reduces Mortality in Hospitalized COVID-19 Patients Through Endothelial Barrier Protection and Immunomodul...

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospi...

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Presentation of 'IV imatinib in severe Covid-19' study result at ERS, ESICM and ATS congresses

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Data management and validation plan M12

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Data management and validation plan final

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Data validation and management plan

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Pathophysiology report & manuscript

Project: Impentri

Updated at: 31-07-2023

Show more information

Project acronym Impentri

Periodic Reporting for period 1 - Impentri (Development of Impentri, an intravenous imatinib formulation for Covid-19 ac...

Project: Impentri

Updated at: 08-03-2023

Show more information

Project acronym Impentri

Resources

Selected filters:

'IV imatinib in severe Covid-19' study peer reviewed publication

Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib s...

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

'Oral imatinib in severe Covid-19' study peer reviewed publication

Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients ...

90-Day Clinical Outcome of Hospitalized Covid-19 Patients Treated with Imatinib

Long-term clinical outcomes of COVID-19 patients treated with imatinib

The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of...

Oral Imatinib Reduces Mortality in Hospitalized COVID-19 Patients Through Endothelial Barrier Protection and Immunomodul...

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospi...

Presentation of 'IV imatinib in severe Covid-19' study result at ERS, ESICM and ATS congresses

Data management and validation plan M12

Data management and validation plan final

Data validation and management plan

Pathophysiology report & manuscript

Periodic Reporting for period 1 - Impentri (Development of Impentri, an intravenous imatinib formulation for Covid-19 ac...